Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Clinical trial NCT06454578 · RECRUITING
Trial details
- NCT number
- NCT06454578
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.